Seble Lemma — 4 Patents at Glaxosmithkline Intellectual Property Development Limited

Seble Lemma has been granted 4 US patents while listed as an inventor at Glaxosmithkline Intellectual Property Development Limited. The first was granted in 2018 and the most recent in December 2019. Seble Lemma ranks #1,080,739 of 4,157,543 US inventors in our database (top 26.0%). Patent records list Seble Lemma in Stevenage, GB.

Issued Patents All Time

Showing 1–4 of 4 patents

Patent #	Title	Co-Inventors	Date
10513517	Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases	Niall Andrew Anderson, Ian Baxter Campbell, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, Simon John Fawcett MacDonald +2 more	2019-12-24
10487080	Naphthyridines as integrin antagonists	Niall Andrew Anderson, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, John Martin Pritchard, Panayiotis Alexandrou Procopiou +1 more	2019-11-26
10144733	Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases	Niall Andrew Anderson, Ian Baxter Campbell, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, Simon John Fawcett MacDonald +2 more	2018-12-04
10004724	Compounds alpha v beta 6 integrin antagonists	Niall Andrew Anderson, Matthew Howard James Campbell-Crawford, Ashley Paul Hancock, Simon John Fawcett MacDonald, John Martin Pritchard +2 more	2018-06-26